Other frequently mutated genes in the tumor tissue samples used in our lung cancer study were FLT3 (altered in 87% of the samples), KDR (84%), CSF1R (72%), PIK3CA (59%), and ERBB4 (53%). The gene discussed is FLT3; the disease is lung carcinoma.